administration of vaccines stored at 22F; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received Men B NVS (Bexsero) (batch number ABX29BA, expiry date 30th May 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, Men ACWY-CRM NVS (Menveo) (batch number AMVA586A, expiry date 30th August 2022) for prophylaxis, DTPa-IPV (Kinrix) (batch number 2NT2N, expiry date 7th May 2023) for prophylaxis, dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) (batch number 5S945, expiry date 6th April 2023) for prophylaxis, dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) (batch number 77X47, expiry date 22nd December 2023) for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis and dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero, Bexsero Pre-Filled Syringe Device, Menveo, Kinrix, Kinrix Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Engerix B, Pediarix and Pediarix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero, Bexsero Pre-Filled Syringe Device, Menveo, Kinrix, Kinrix Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device, Infanrix, Infanrix Pre-Filled Syringe Device, Engerix B, Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-JUL-2022 Reporter's Comment: The reporter stated that the administration of Bexsero, Menveo, Kinrix, Pediarix, Boostrix, Infanrix and Engerix-B to multiple patients, that was stored at 22-degree Fahrenheit for 30 minutes. The excursion occurred on 6th April 2022 and these vaccines was administered until May 2022. The reporter consented to follow up. Additional supportive information: Bexsero, Menveo, Kinrix, Pediarix, Boostrix, Infanrix and Engerix-B these vaccines was stored at 22-degree Fahrenheit for 30 minutes which led to incorrect storage of drug. This was 1 out of 12 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR103706:Same reporter US-GLAXOSMITHKLINE-US2022AMR103707:Same reporter US-GLAXOSMITHKLINE-US2022102741:Same reporter US-GLAXOSMITHKLINE-US2022AMR103705:Same reporter US-GLAXOSMITHKLINE-US2022AMR103709:Same reporter US-GLAXOSMITHKLINE-US2022AMR103710:Same reporter US-GLAXOSMITHKLINE-US2022AMR103711:Same reporter US-GLAXOSMITHKLINE-US2022AMR103712:Same reporter US-GLAXOSMITHKLINE-US2022AMR103713:Same reporter US-GLAXOSMITHKLINE-US2022AMR103714:Same reporter US-GLAXOSMITHKLINE-US2022AMR103715:Same reporter